Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001843162 | SCV001349079 | uncertain significance | Cardiac arrhythmia | 2019-06-05 | criteria provided, single submitter | clinical testing | This missense variant replaces glycine with arginine at codon 1406 in the transmembrane DIII domain of the SCN5A protein. Computational prediction tools and conservation analyses suggest that this variant may have deleterious impact on the protein function. Computational splicing tools suggest that this variant may not impact RNA splicing. To our knowledge, functional assays have not been performed for this variant. This variant has been reported in an individual affected with Brugada syndrome (PMID: 12106943) and an individual referred for Brugada syndrome genetic testing (PMID: 20129283). This variant has been reported in 8 individuals from 2 families affected with cardiac conduction disease and/or BrS (Mizusawa, 2016). However, phenotype status of these carriers were not provided. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |